Aurelix Bio is a clinical development platform built to accelerate rare disease therapies from concept to clinic.

The company provides unified, sponsor-grade leadership across development, regulatory strategy, and execution — eliminating fragmentation and driving programs forward with clarity, accountability, and speed.

By aligning investigators, partners, and stakeholders under a single coordinated plan, Aurelix Bio transforms complex, high-risk programs into structured, regulator-ready pathways toward clinical milestones and patient impact.

Aurelix partners with patient advocacy organizations, early-stage biotech companies, and academic teams navigating critical translational inflection points, bringing disciplined program stewardship, strategic decision-making, and predictable progress to areas where resources are constrained but urgency is high.

Aurelix Bio

Org chart

Teams

Offices